SCHEMBL23457943

SCHEMBL23457943

CCN(CC)c1cccc2cccc(C)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.43
▸ GAA P10253 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ELANE P08246 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP2A6 P11509 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ LCK P06239 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ GRK6 P43250 1/20 0.34
▸ HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29919897 1.00 MAPT (0.43) MAPTGAAKDM4EELANEMEN1
SCHEMBL8680185 0.87 MAPT (0.56) MAPTGAAKDM4EELANEMEN1
SCHEMBL29851874 0.87 MAPT (0.56) MAPTGAAKDM4EELANEMEN1
SCHEMBL17384923 0.78 KDM4E (0.52) MAPTGAAKDM4EMEN1KMT2A
SCHEMBL4300630 0.77 TRPA1 (0.39) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL10258743 0.77 GAA (0.74) MAPTGAAKDM4EMEN1KMT2A
SCHEMBL328909 0.76 CYP3A4 (0.46) MAPTKDM4EALDH1A1CYP3A4TSHR
SCHEMBL29520654 0.76 CYP3A4 (0.46) MAPTKDM4EALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL10630985 0.75 ALDH1A1 (0.38) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL17365996 0.74 MAPT (0.42) MAPTGAAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 — — US disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 — — US disclosed
US-12031098-B2 Method of marking a petroleum hydrocarbon SICPA HOLDING SA (CH) 2024-07-09 — — US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 — — EP disclosed
US-20230265243-A1 DUAL CATALYST SYSTEM FOR MASS VINYL ADDITION AND CATIONIC POLYMERIZABLE COMPOSITIONS PROMERUS, LLC (US) 2023-08-24 — — US disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 — — US disclosed
US-20230029106-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2023-01-26 — — US disclosed
EP-4069807-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS Sicpa Holding SA (CH) 2022-10-12 — — EP disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 MAPT 4817/4885GAA 4673/4885KDM4E 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback